cancerALLautoimmune diseasesCLLSLEGvHDgraft-versus-host diseaseNSG miceGPC3Medicilon’s Ethics Board
…fective allogeneic platform for CAR-based immunotherapy in both cancer and autoimmune diseases, providing a strong foundation for furt…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 10,501–10,560 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Multiple Acyl-CoA Dehydrogenase Deficiency1Multiple Organs Failure (MOF)1Multiple acyl-CoA dehydrogenase deficiency (MADD)1Multiple drug intolerance syndrome (MDIS)1Multiple endocrine neoplasia type 11Multiple endocrine neoplasia type 2B1Multiple evanescent white dot syndrome1Multiple intracranial unruptured aneurysms1Multiple myeloma (MM)1Multiple sclerosis64251Munchmeyer disease1Muscle damage1Musculoskeletal injuries (MSKI)1MvD-D1Myasthenia1Mycobacteria abscessus lung infection1Mycobacterium avium complex pulmonary disease1Mycobacterium avium subspecies paratuberculosis1Mycobacterium marinum1Mycobacterium tuberculosis infections1Mycoplasma contamination1Mycoplasma genitalium infection1Mycoplasma genitalium infections1Mycotic aneurysms (MAs)1Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)1Myelin oligodendrocyte glycoprotein-antibody disease1Myeloma49071049171Myeloperoxidase (MPO) deficiency1Myocardial infarction35301Myocardial scar or fibrosis1Myocarditis3971Myoclonic1Myoclonic seizures1Myofascial pain syndrome (MPS)1Myoma uteri1Myopic strabismus fixus1Myositis-associated interstitial lung disease (MAILD)1Myotonic dystrophy type 1 (DM1)1Myotonic dystrophy type 2 (DM2)1Myxoid pleiomorphic liposarcoma1Ménétrier’s disease1Müllerian agenesis1Müllerian duct anomalies1Müllerian duct cyst1N-methyl-d-aspartate receptor encephalitis1N. gonorrhoeae-positive1N. meningitidis1N24HSWRD1N3 diseasea1NAA-related pmSAH1NASDHs1NASH-related LC1NASH-related hepatocellular carcinoma1NBCCS1NBI1NBP1NBS1NCDs) among people living with HIV1NCSs1NCTH1
Articles mentioning diseases
23,712 articles · page 220 of 1976COVID-19advanced/metastatic canceradvanced/metastatic solid tumorshepatocellular carcinomatype 2 diabetes mellitusECOG Performance StatusNP-101
….0002). A double-blind, randomized, placebo-controlled trial in COVID-19 patients14 demonstrated that NP-101 led to a faster decline in …
HNSCCPembrolizumabmicvo
…y pretreated patients across multiple tumor types, particularly HNSCC, with a manageable safety profile. Therefore, exploring the com…
94.6%
Acute myeloid leukemianeuroblastomaAMLNKTR-255
…Background Acute myeloid leukemia (AML) accounts for 25% of acute leukemias in children and 33% i…
BCCaBCClocally advanced or metastatic diseasecemiplimab
…nowledge and competence (K/C) related to choosing patients with BCC who should receive systemic therapies, including IOs. We used a…
metastatic melanomaCVDmyocarditisipilimumabPembrolizumabSEER 18surgical treatmentAmerican Heart AssociationN Engl J MedJ Am Coll Cardiol
…ne checkpoint inhibitors (ICIs) have revolutionized therapy for metastatic melanoma, substantially improving survival outcomes. 1 2 However, as ICI…
colorectal cancerCRCSeverance Hospital
… FOXP3+CD25+CD127– Treg cells in colorectal cancer.KRAS-mutated colorectal cancer (CRC) tumors exhibited significantly higher frequencies of both…
Small cell lung cancerSCLCataxia telangiectasiatopotecanM6620chemotherapyVX970
…Background Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Recent cl…
head and neck squamous cell carcinomaRenal cell carcinomanon-small cell lung cancerRCCimmunotherapyProvidence St. Joseph Health Institutional Review Board – Oregonimmunotherapy-refractory
…cell-cell interactions among a cohort of primary breast cancer, head and neck squamous cell carcinoma, non-small cell lung cancer, and RCC specimens. Putative tumor …
melanomaTalimogene laherparepvectalimogene laherparapvecpembrolizumabMassachusetts General HospitalMGHMGH Pathology Flow Core
…, Cohen S. Genetic factors associated with clinical response in melanoma patients treated with talimogene laherparapvec: a single-instit…
glioblastomaTIMP-1IACUC #2019-0042
… may serve as a novel immunoregulatory marker in the irradiated glioblastoma tumor microenvironment. Ongoing studies will determine whether …
acute myeloid leukemiaAMLazacitidinevenetoclax
…decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia. Blood. 2016. PMID: 26796361; PMCID: PMC4817311.Esposito CL, Au…